UBS GROUP AG-REG (0UB.DE) Fundamental Analysis & Valuation

FRA:0UB • CH0244767585

33.14 EUR
-0.67 (-1.98%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 0UB.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

0UB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 124 industry peers in the Capital Markets industry. Both the profitability and financial health of 0UB have multiple concerns. 0UB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. 0UB.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 0UB was profitable.
  • 0UB had a positive operating cash flow in the past year.
  • 0UB had positive earnings in 4 of the past 5 years.
  • Of the past 5 years 0UB 4 years had a positive operating cash flow.
0UB.DE Yearly Net Income VS EBIT VS OCF VS FCF0UB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B -40B 60B 80B

1.2 Ratios

  • With a Return On Assets value of 0.45%, 0UB perfoms like the industry average, outperforming 44.35% of the companies in the same industry.
  • 0UB has a Return On Equity (8.16%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.45%
ROE 8.16%
ROIC N/A
ROA(3y)0.87%
ROA(5y)0.77%
ROE(3y)17.12%
ROE(5y)14.94%
ROIC(3y)N/A
ROIC(5y)N/A
0UB.DE Yearly ROA, ROE, ROIC0UB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • The Profit Margin of 0UB (14.19%) is comparable to the rest of the industry.
  • 0UB's Profit Margin has declined in the last couple of years.
  • 0UB does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 14.19%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-20.78%
PM growth 5Y-6.71%
GM growth 3YN/A
GM growth 5YN/A
0UB.DE Yearly Profit, Operating, Gross Margins0UB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. 0UB.DE Health Analysis

2.1 Basic Checks

  • 0UB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
0UB.DE Yearly Shares Outstanding0UB.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
0UB.DE Yearly Total Debt VS Total Assets0UB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

  • The Debt to FCF ratio of 0UB is 180.19, which is on the high side as it means it would take 0UB, 180.19 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 180.19, 0UB perfoms like the industry average, outperforming 59.68% of the companies in the same industry.
  • A Debt/Equity ratio of 4.12 is on the high side and indicates that 0UB has dependencies on debt financing.
  • The Debt to Equity ratio of 0UB (4.12) is worse than 62.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.12
Debt/FCF 180.19
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
0UB.DE Yearly LT Debt VS Equity VS FCF0UB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
0UB.DE Yearly Current Assets VS Current Liabilites0UB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 0UB.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 55.26% over the past year.
  • 0UB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.80% yearly.
EPS 1Y (TTM)55.26%
EPS 3Y1.75%
EPS 5Y5.8%
EPS Q2Q%60.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.38%

3.2 Future

  • 0UB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.17% yearly.
  • Based on estimates for the next years, 0UB will show a small growth in Revenue. The Revenue will grow by 3.74% on average per year.
EPS Next Y42.76%
EPS Next 2Y32.72%
EPS Next 3Y26.63%
EPS Next 5Y22.17%
Revenue Next Year5.1%
Revenue Next 2Y4.28%
Revenue Next 3Y4.4%
Revenue Next 5Y3.74%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
0UB.DE Yearly Revenue VS Estimates0UB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B
0UB.DE Yearly EPS VS Estimates0UB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. 0UB.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.25, which indicates a correct valuation of 0UB.
  • Based on the Price/Earnings ratio, 0UB is valued a bit cheaper than the industry average as 70.97% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.29. 0UB is valued slightly cheaper when compared to this.
  • 0UB is valuated reasonably with a Price/Forward Earnings ratio of 11.37.
  • Based on the Price/Forward Earnings ratio, 0UB is valued cheaply inside the industry as 85.48% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of 0UB to the average of the S&P500 Index (24.60), we can say 0UB is valued rather cheaply.
Industry RankSector Rank
PE 16.25
Fwd PE 11.37
0UB.DE Price Earnings VS Forward Price Earnings0UB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, 0UB is valued a bit cheaper than the industry average as 62.10% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 62.21
EV/EBITDA N/A
0UB.DE Per share data0UB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 0UB's earnings are expected to grow with 26.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)2.8
EPS Next 2Y32.72%
EPS Next 3Y26.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 0UB.DE Dividend Analysis

5.1 Amount

  • No dividends for 0UB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

0UB.DE Fundamentals: All Metrics, Ratios and Statistics

UBS GROUP AG-REG

FRA:0UB (3/6/2026, 7:00:00 PM)

33.14

-0.67 (-1.98%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners58.99%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap110.74B
Revenue(TTM)N/A
Net Income(TTM)7.34B
Analysts74.62
Price Target42.01 (26.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.61
Dividend Growth(5Y)0.29%
DP39.06%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.4%
Min EPS beat(2)-1.54%
Max EPS beat(2)40.34%
EPS beat(4)1
Avg EPS beat(4)2.26%
Min EPS beat(4)-25.26%
Max EPS beat(4)40.34%
EPS beat(8)4
Avg EPS beat(8)-2.9%
EPS beat(12)5
Avg EPS beat(12)-30.18%
EPS beat(16)9
Avg EPS beat(16)-17.85%
Revenue beat(2)0
Avg Revenue beat(2)-2.98%
Min Revenue beat(2)-4.59%
Max Revenue beat(2)-1.36%
Revenue beat(4)0
Avg Revenue beat(4)-3.29%
Min Revenue beat(4)-5.19%
Max Revenue beat(4)-1.36%
Revenue beat(8)4
Avg Revenue beat(8)1.71%
Revenue beat(12)8
Avg Revenue beat(12)3.5%
Revenue beat(16)12
Avg Revenue beat(16)4.87%
PT rev (1m)-2.83%
PT rev (3m)12.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.59%
EPS NY rev (1m)-0.39%
EPS NY rev (3m)0.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 16.25
Fwd PE 11.37
P/S 2.48
P/FCF 62.21
P/OCF 29.82
P/B 1.42
P/tB 1.54
EV/EBITDA N/A
EPS(TTM)2.04
EY6.16%
EPS(NY)2.91
Fwd EY8.79%
FCF(TTM)0.53
FCFY1.61%
OCF(TTM)1.11
OCFY3.35%
SpS13.39
BVpS23.27
TBVpS21.46
PEG (NY)0.38
PEG (5Y)2.8
Graham Number32.68
Profitability
Industry RankSector Rank
ROA 0.45%
ROE 8.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 14.19%
GM N/A
FCFM 3.98%
ROA(3y)0.87%
ROA(5y)0.77%
ROE(3y)17.12%
ROE(5y)14.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-20.78%
PM growth 5Y-6.71%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 4.12
Debt/FCF 180.19
Debt/EBITDA N/A
Cap/Depr 61.14%
Cap/Sales 4.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 28.05%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)59.2%
Cap/Depr(5y)70.42%
Cap/Sales(3y)4.12%
Cap/Sales(5y)4.52%
Profit Quality(3y)167.93%
Profit Quality(5y)287.17%
High Growth Momentum
Growth
EPS 1Y (TTM)55.26%
EPS 3Y1.75%
EPS 5Y5.8%
EPS Q2Q%60.87%
EPS Next Y42.76%
EPS Next 2Y32.72%
EPS Next 3Y26.63%
EPS Next 5Y22.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.38%
Revenue Next Year5.1%
Revenue Next 2Y4.28%
Revenue Next 3Y4.4%
Revenue Next 5Y3.74%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.27%
EBIT Next 3Y27.54%
EBIT Next 5Y24.53%
FCF growth 1Y-95.53%
FCF growth 3Y-64.98%
FCF growth 5Y-41.22%
OCF growth 1Y-91.01%
OCF growth 3Y-52.92%
OCF growth 5Y-30.14%

UBS GROUP AG-REG / 0UB.DE FAQ

What is the ChartMill fundamental rating of UBS GROUP AG-REG (0UB.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 0UB.DE.


Can you provide the valuation status for UBS GROUP AG-REG?

ChartMill assigns a valuation rating of 6 / 10 to UBS GROUP AG-REG (0UB.DE). This can be considered as Fairly Valued.


How profitable is UBS GROUP AG-REG (0UB.DE) stock?

UBS GROUP AG-REG (0UB.DE) has a profitability rating of 2 / 10.


What are the PE and PB ratios of UBS GROUP AG-REG (0UB.DE) stock?

The Price/Earnings (PE) ratio for UBS GROUP AG-REG (0UB.DE) is 16.25 and the Price/Book (PB) ratio is 1.42.


Can you provide the financial health for 0UB stock?

The financial health rating of UBS GROUP AG-REG (0UB.DE) is 1 / 10.